Alpha adrenergic blockers in the treatment of benign hyperplasia of the prostate.
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 32 (1) , 67-71
- https://doi.org/10.1023/a:1007108201320
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and futureBritish Journal of Urology, 1997
- Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia)British Journal of Urology, 1997
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- DoxazosinDrugs, 1995
- Benign prostatic hyperplasia. Its natural history, epidemiologic characteristics, and surgical treatmentArchives of Family Medicine, 1992
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- Phenoxybenzamine for benign prostatic obstruction review of 200 casesUrology, 1981
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978